16:44 EST Cogent Biosciences (COGT) files automatic mixed securities shelf
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COGT:
- Cogent Biosciences Advances Precision Therapies in Q3 2025
- Cogent Biosciences: Hold Rating Amid Anticipated Positive Data and Pipeline Developments
- Cogent Biosciences reports Q3 net loss $80.9M vs. $70.6M last year
- Cogent Biosciences sees cash runway into 2027
- Cogent Biosciences Advances FGFR2/3 Inhibitor Study in Cancer Treatment